1. Home
  2. Live Updates
  3. சிண்டி கோலின்ஸ்

Live Breaking News & Updates on சிண்டி கோலின்ஸ்

Stay informed with the latest breaking news from சிண்டி கோலின்ஸ் on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in சிண்டி கோலின்ஸ் and stay connected to the pulse of your community

Black History Month - 103.3 KLOU

We're celebrating Black History Month by shouting out some of our favorite sons and daughters throughout the month of February.

Chicago , Illinois , United-states , Cindy-collins , Michelle-esswein , Heartradio-prom , Vic-porcelli , Big-mike , Billy-judi , National-sports-query , Inferno-national-promotions , Sports-format-local-national-mix

Editas Medicine Announces Transition of Chief Scientific Officer


Editas Medicine Announces Transition of Chief Scientific Officer
Editas Medicine Announces Transition of Chief Scientific Officer
CAMBRIDGE, Mass., Jan. 11, 2021 — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that its Chief Scientific Officer, Charles Albright, Ph.D., is stepping down from the Company on January 15 to pursue another opportunity. A search is underway to find a successor to Dr. Albright.
“On behalf of the entire Editas team, I sincerely thank Charlie for his many contributions in pioneering the field of genomic medicine. Charlie has been instrumental in building our scientific organization, defining our programs, and advancing our pipeline. We wish him all the best as he pursues his new role,” said Cindy Collins, President and Chief Executive Officer, Editas Medicine.

Cambridge , Cambridgeshire , United-kingdom , Charles-albright , Cindy-collins , Cristi-barnett , Exchange-commission , Company-on , Editas-medicine-inc , Nasdaq , Editas-medicine , Chief-scientific-officer